As the alternative protein landscape continues to grow and evolve, how can novel technologies be used to address existing scalability, cost, and product quality challenges? Learn about the burgeoning field of optogenetics and how optogenetic tools are being applied across diverse alternative protein applications to unlock major solutions for the industry at-large. Prolific Machines Co-Founder & CTO, Max Huisman, PhD, will discuss how this technology works, provide insights around where it is heading, and address questions companies might have when considering this new technology.

‍